Scientific Publications Database
Article Title: Efficacy and Safety of Second- or Third-Line Nab-Paclitaxel plus Durvalumab in Patients with Advanced NSCLC (ABOUND.2L+)Authors: Morgensztern, D.; Govindan, R.; Cobo, M.; Ponce Aix, S.; Postmus, P. E.; Lewanski, C.; Bennouna, J.; Fischer, J.; Juan-Vidal, O.; Stewart, D.; Ardizzoni, A.; Bhore, R.; Wolfsteiner, M.; Reck, M.; Talbot, D.; Ong, T. J.
Journal: JOURNAL OF THORACIC ONCOLOGY Volume 13 Issue 10
Date of Publication:2018
Abstract:
.